KDR and breast carcinoma: To understand the inhibition of monacolin X at IC50 concentration on tumor angiogenesis in breast cancer through VEGFR2 downstream signaling pathway, immunofluorescence (IF) analysis was performed for the downstream cascade of the VEGFR2 signaling pathway.